시장보고서

상품코드

1808843

세계의 비침습적 산전 검사 시장 : 검사 유형별, 기술별, 용도별, 최종 사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Non-invasive Prenatal Testing Market, By Test Type, By Technology, By Application, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

발행일: 2025년 08월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 301 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

비침습적 산전 검사 시장 규모는 2024년에 72억 1,029만 달러로 평가되어 2025-2032년에 걸쳐 14.41%의 연평균 성장률(CAGR)로 성장할 전망입니다.

비침습적 산전 검사(NIPT)는 다운증후군, 에드워즈 증후군, 파타우 증후군과 같은 염색체 이상을 확인하기 위해 임산부의 혈류 내 태아 DNA를 검사하는 선별 검사 기술입니다. 양수천자나 융모막 샘플링과 같은 침습적 방법에 비해 안전한 대안을 제공하여 산모와 태아 모두의 위험을 감축합니다. NIPT의 채택은 유전 질환에 대한 인식 증가, 시퀀싱 기술 발전, 그리고 조기 및 정확한 태아 건강 평가에 대한 수요 증가에 힘입어 촉진되고 있습니다.

산전 관리 인프라 개선과 맞춤형 의약품에 대한 강조 증가도 시장을 뒷받침하고 있습니다. 의료 전문가와 예비 부모 모두 정확성, 편의성, 비침습적 접근성으로 인해 NIPT를 점점 더 선택하고 있습니다. 또한 NIPT를 포괄적인 산전 검사 패널과 통합함으로써 임상적 관련성이 확대되고 있습니다. 그러나 윤리적 문제와 규제 체계는 여전히 시장 동향에 영향을 미치고 있습니다. 전 세계 고위험 임신의 증가도 수요를 촉진하여 검사 기술의 지속적인 혁신을 이끌고 있습니다.

비침습적 산전 검사 시장 - 시장 역학

안전하고 조기, 정확한 태아 유전자 선별 검사에 대한 수요 증가

예비 산모들 사이에서 비침습적이고 저위험 산전 검사에 대한 선호도가 높아지면서 비침습적 산전 검사(NIPT) 수요가 상당하게 증가하여 시장 성장을 촉진하고 있습니다. 미국 산부인과 학회(ACOG)에 따르면 양수천자 및 융모막 샘플링과 같은 기존 침습적 시술은 약 0.1-0.3%의 유산 위험을 수반하는 반면, NIPT는 간단한 모체 혈액 채취를 통해 안전한 대안을 제공합니다.

NIPT는 임신 10주차부터 가능한 조기 및 정확한 염색체 이상 검출을 가능하게 합니다. 여기에는 트리소미 21(다운증후군), 트리소미 18(에드워즈증후군), 트리소미 13(파투증후군) 등이 포함됩니다. 연구에 따르면 NIPT는 다운증후군 검출에 대해 99% 이상의 민감도와 특이도를 보여 검사 결과에 대한 신뢰도를 크게 향상시킵니다. 세포 외 태아 DNA 분석 기술의 지속적인 고급 발전으로 민감도와 특이도가 모두 향상되어 NIPT는 조기 선별 검사를 위한 신뢰할 수 있는 옵션이 되었습니다. 의료 서비스 제공자들은 점점 더 안전한 산전 관리 프로토콜의 일환으로 NIPT를 권장하고 있습니다.

비침습적 산전 검사 시장 - 세분화 분석

세계의 비침습적 산전 검사 시장은 검사 유형, 기술, 용도, 최종 사용자 및 지역에 따라 세분화됩니다.

시장은 검사 유형에 따라 세 가지 범주로 구분됩니다 : 시퀀싱 기반 NIPT, 마이크로어레이 기반 NIPT, PCR 기반 NIPT. 시퀀싱 기반 NIPT 부문은 높은 정확도와 광범위한 검출 능력으로 인해 시장을 주도합니다. 이 방법은 차세대 시퀀싱을 통해 무세포 태아 DNA를 분석하여 여러 염색체 이상을 동시에 검출할 수 있습니다. 시퀀싱 방식은 PCR 또는 마이크로어레이 방식에 비해 더 높은 민감도를 제공하여 모체 혈액 내 낮은 농도의 태아 DNA 분획도 검출할 수 있습니다.

이러한 포괄적인 접근 방식은 신뢰할 수 있는 다중 조건 산전 검진을 원하는 의료 서비스 제공자에게 매력적입니다. 시퀀싱 처리량 지속적 개선과 비용 절감은 접근성과 채택률을 향상시킵니다. 생물정보학 공구 통합 능력은 임상적 해석을 더욱 강화합니다. 결과적으로 시퀀싱 기반 검사는 일상적인 NIPT에 선호되어 이 부문이 시장을 주도하고 있습니다.

시장은 기술에 따라 차세대 시퀀싱(NGS), 중합 효소 연쇄반응(PCR), 마이크로어레이 등으로 분류됩니다. 비침습적 산전 검사(NIPT) 시장에서 기술별 가장 지배적인 부문은 차세대 시퀀싱(NGS)입니다. NGS는 모체 혈액에서 태아 DNA를 매우 정확하고 포괄적으로 분석할 수 있게 함으로써 산전 검사 분야에 혁신을 가져왔습니다. 일반적인 삼염색체증(예 : 21번, 18번, 13번 삼염색체증), 미세 결실, 성염색체 수적 이상 등 광범위한 유전적 이상을 검출할 수 있는 능력 덕분에 NGS는 임상의와 진단 실험실에서 선호하는 기술이 되었습니다.

기존 방법과 달리 NGS는 더 높은 민감도와 특이도를 제공하여 양수천식과 같은 침습적 확인 검사의 필요성을 감축합니다. 확장성, 처리량 및 비용 효율성은 특히 고급 의료 인프라를 갖춘 선진국에서 채택을 더욱 촉진했습니다. 일루미나(Illumina), 로슈(Roche), 네이터라(Natera)와 같은 주요 진단 기업들은 NIPT 솔루션에 NGS 플랫폼을 활용하여 지속적인 혁신을 촉진하고 있습니다.

비침습적 산전 검사 시장 - 지리적 인사이트

북미는 고급 의료 인프라와 유전자 검사 기술의 조기 도입으로 비침습적 산전 검사(NIPT)의 선도적 시장 지위를 뒷받침하고 있습니다. 미국은 산전 건강에 대한 인식 제고, 검사가 필요한 대규모 임신 건수, 제품 승인을 간소화하는 명확한 규제 체계에 힘입어 지역 시장을 촉진하고 있습니다. 점점 더 많은 의료 제공자들이 이제 정기 산전 관리에 NIPT를 포함되고 있으며, 검진 채택을 촉진하는 의료 지침과 인식 제고 활동이 이를 더욱 뒷받침하고 있습니다.

미국은 또한 여러 주요 업체와 연구 기관이 위치한 NIPT 혁신의 중심지입니다. 차세대 시퀀싱과 효율적인 실험실 시스템의 사용 증가로 처리 시간이 상당하게 감축되어 검사가 더욱 접근 가능해졌습니다. 산부인과 의사들이 고위험군뿐만 아니라 일반 위험군 임신부에게도 NIPT를 권장함에 따라 수요는 계속 증가하고 있습니다.

비침습적 산전 검사 시장 - 경쟁 구도

비침습적 산전 검사 시장의 경쟁 미래는 빠른 기술적 발전, 강력한 연구개발(R&D) 투자, 주요 업체 간의 전략적 협력으로 특징지어집니다. 기업들은 검사 패널을 확대하여 더 광범위한 유전적 질환이 포함되도록 주력하고 있습니다. 시퀀싱, 최종 사용자 및 생물정보학 분야의 혁신은 검사 정확도를 향상시키고 처리 시간을 감축하여 경쟁 엣지를 제공합니다.

의료 서비스 제공자 및 보험사와의 협력은 시장 침투율과 보험 적용 범위를 개선하는 데 도움이 됩니다. 일부 업체들은 고객 기반 확대를 위해 신흥 시장으로의 지역적 확장을 추진하고 있습니다. 경쟁력 있는 가격 책정과 검사 솔루션 맞춤화 역시 중요한 역할을 합니다. 또한 규제 준수 및 데이터 개인정보 보호 고려사항은 핵심 경쟁 요인입니다. 합병, 인수 및 파트너십은 시장 경쟁을 더욱 격화시킵니다. 기업들은 NIPT의 이점에 대한 인식을 높이기 위해 교육 프로그램에도 투자하고 있습니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 네덜란드
- 스웨덴
- 러시아
- 폴란드
- 기타
아시아태평양
- 개요
- 아시아태평양의 주요 제조업체
- 중국
- 인도
- 일본
- 한국
- 호주
- 인도네시아
- 태국
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 튀르키예
- 알제리
- 이집트
- 기타

제12장 주요 벤더 분석 - 비침습적 산전 검사 업계

경쟁 대시보드
- Competitive Benchmarking
- Competitive Positioning
기업 프로파일
- Illumina, Inc.
- Roche Diagnostics
- BGI Genomics
- Myriad Genetics, Inc.
- Natera, Inc.
- PerkinElmer, Inc.
- Invitae Corporation
- Thermo Fisher Scientific, Inc.
- Laboratory Corporation of America Holdings(LabCorp)
- QIAGEN NV
- Berry Genomics Co., Ltd.
- Agilent Technologies, Inc.
- Eurofins Scientific
- Fulgent Genetics
- Genesis Genomics
- GeneDx, Inc.
- CooperGenomics
- Congenica
- GenePlanet
- Integrated Genetics

제13장 애널리스트의 전방위적 전망

HBR 25.09.29

Non-invasive Prenatal Testing Market size was valued at US$ 7,210.29 Million in 2024, expanding at a CAGR of 14.41% from 2025 to 2032.

Non-invasive prenatal testing (NIPT) is a screening technique that examines fetal DNA in a pregnant woman's bloodstream to identify chromosomal abnormalities such as Down syndrome, Edwards syndrome, and Patau syndrome. It offers a safer alternative to invasive methods like amniocentesis and chorionic villus sampling, reducing risks for both mother and baby. The adoption of NIPT is being fueled by growing awareness of genetic conditions, advancements in sequencing technologies, and the rising demand for early and accurate fetal health assessments.

The market is further supported by improved prenatal care infrastructure and the growing emphasis on personalized medicine. Both healthcare professionals and expectant parents are increasingly choosing NIPT for its precision, ease, and non-invasive approach. Additionally, the integration of NIPT with comprehensive prenatal screening panels is expanding its clinical relevance. However, ethical concerns and regulatory frameworks continue to influence market trends. The global increase in high-risk pregnancies is also driving demand, prompting continued innovation in testing technologies.

Non-invasive Prenatal Testing Market- Market Dynamics

Rising demand for safe, early, and accurate fetal genetic screening tests.

The growing preference for non-invasive and low-risk prenatal testing among expectant mothers is significantly boosting the demand for Non-Invasive Prenatal Testing (NIPT), driving market growth. In contrast to traditional invasive procedures-such as amniocentesis and chorionic villus sampling-that carry a miscarriage risk of approximately 0.1-0.3% according to the American College of Obstetricians and Gynecologists (ACOG), NIPT offers a safe alternative through a simple maternal blood draw.

NIPT enables early and accurate detection of chromosomal abnormalities, such as trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome), often as early as the 10th week of pregnancy. Studies have shown that NIPT has a sensitivity and specificity of over 99% for detecting Down syndrome, greatly enhancing confidence in test outcomes. Ongoing advancements in cell-free fetal DNA analysis have improved both sensitivity and specificity, making NIPT a trusted option for early screening. Healthcare providers are increasingly recommending NIPT as part of safer prenatal care protocols.

Non-invasive Prenatal Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.41% over the forecast period (2025-2032)

Based on Test Type segmentation, sequencing-based NIPT was predicted to show maximum market share in the year 2024

Based on Technology segmentation, Next-Generation Sequencing (NGS) were the leading Technology in 2024

Based on Application segmentation, Down Syndrome Screening was the leading Application in 2024

On the basis of region, North America was the leading revenue generator in 2024

Non-invasive Prenatal Testing Market- Segmentation Analysis:

The Global Non-invasive Prenatal Testing Market is segmented on the basis of Test Type, Technology, Application, End-user, and Region.

The market is divided into three categories based on Test Type: Sequencing-based NIPT, Microarray-based NIPT, and PCR-based NIPT. The sequencing-based NIPT segment dominates due to its high accuracy and broad detection capabilities. This method analyzes cell-free fetal DNA with next-generation sequencing, allowing detection of multiple chromosomal abnormalities simultaneously. Sequencing End-user provides greater sensitivity compared to PCR or microarray methods, enabling detection of even low fetal DNA fractions in maternal blood.

This comprehensive approach appeals to healthcare providers seeking reliable, multi-condition prenatal screening. Continuous improvements in sequencing throughput and cost reduction enhance its accessibility and adoption. The ability to integrate bioinformatics tools further strengthens clinical interpretation. As a result, sequencing-based tests are often preferred for routine NIPT, making this segment the market leader.

The market is divided into four categories based on Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, and Others. The most dominant segment in the Non-Invasive Prenatal Testing (NIPT) market by technology is Next-Generation Sequencing (NGS). NGS has revolutionized the field of prenatal screening by enabling highly accurate and comprehensive analysis of fetal DNA from maternal blood. Its ability to detect a wide range of genetic abnormalities, including common trisomies (such as Trisomy 21, 18, and 13), microdeletions, and sex chromosome aneuploidies, has made it the preferred technology among clinicians and diagnostic laboratories.

Unlike traditional methods, NGS offers higher sensitivity and specificity, reducing the need for invasive confirmatory tests like amniocentesis. Its scalability, throughput, and cost-efficiency have further boosted its adoption, particularly in developed countries with advanced healthcare infrastructure. Major diagnostic companies like Illumina, Roche, and Natera leverage NGS platforms for their NIPT solutions, driving continuous innovation.

Non-invasive Prenatal Testing Market- Geographical Insights

North America remains a leading market for Non-Invasive Prenatal Testing (NIPT), supported by its advanced healthcare infrastructure and early adoption of genetic screening technologies. The United States dominates the regional landscape, driven by rising awareness of prenatal health, a large volume of pregnancies requiring screening, and well-defined regulatory frameworks that streamline product approvals. A growing number of healthcare providers now include NIPT in routine prenatal care, further supported by medical guidelines and awareness initiatives that promote testing adoption.

The U.S. is also a hub for innovation in NIPT, home to several major industry players and research institutions. The increasing use of next-generation sequencing and efficient laboratory systems has significantly reduced turnaround times, making the tests more accessible. Demand continues to rise as obstetricians recommend NIPT not only for high-risk but also for average-risk pregnancies.

Non-invasive Prenatal Testing Market- Competitive Landscape:

The competitive landscape of the Non-invasive Prenatal Testing Market is characterized by rapid technological advancements, strong R&D investment, and strategic collaborations among key players. Companies are focusing on expanding their testing panels to include a broader range of genetic conditions. Innovation in sequencing End-user and bioinformatics enhances test accuracy and reduces turnaround times, offering a competitive edge.

Collaborations with healthcare providers and payers help improve market penetration and insurance reimbursement. Some players are pursuing geographic expansion to emerging markets to increase their customer base. Competitive pricing and customization of testing solutions also play important roles. Additionally, regulatory compliance and data privacy considerations are critical competitive factors. Mergers, acquisitions, and partnerships further intensify market rivalry. Companies also invest in educational initiatives to raise awareness about NIPT benefits.

Recent Developments:

In May 2025, Natera, Inc. announced a new expanded NIPT panel targeting additional rare genetic conditions to enhance prenatal screening capabilities.

In April 2025, Illumina, Inc. launched a cloud-based software upgrade for its sequencing platform, improving NIPT data analysis speed and accuracy.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NON-INVASIVE PRENATAL TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Illumina, Inc.
Roche Diagnostics
BGI Genomics
Myriad Genetics, Inc.
Natera, Inc.
PerkinElmer, Inc.
Invitae Corporation
Thermo Fisher Scientific, Inc.
Laboratory Corporation of America Holdings (LabCorp)
QIAGEN N.V.
Berry Genomics Co., Ltd.
Agilent Technologies, Inc.
Eurofins Scientific
Fulgent Genetics
Genesis Genomics
GeneDx, Inc.
CooperGenomics
Congenica
GenePlanet
Integrated Genetics

GLOBAL NON-INVASIVE PRENATAL TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

Sequencing-based NIPT
Microarray-based NIPT
PCR-based NIPT

GLOBAL NON-INVASIVE PRENATAL TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Microarray
Others

GLOBAL NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Down Syndrome Screening
Edwards Syndrome Screening
Patau Syndrome Screening
Sex Chromosome Aneuploidy Screening
Others

GLOBAL NON-INVASIVE PRENATAL TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Hospitals & Clinics
Diagnostic Laboratories
Research Institutes

GLOBAL NON-INVASIVE PRENATAL TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Non-invasive Prenatal Testing Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Non-invasive Prenatal Testing Market Snippet by Test Type
- 2.1.2. Non-invasive Prenatal Testing Market Snippet by Technology
- 2.1.3. Non-invasive Prenatal Testing Market Snippet by Application
- 2.1.4. Non-invasive Prenatal Testing Market Snippet by End-user
- 2.1.5. Non-invasive Prenatal Testing Market Snippet by Country
- 2.1.6. Non-invasive Prenatal Testing Market Snippet by Region
2.2. Competitive Insights

3. Non-invasive Prenatal Testing Key Market Trends

3.1. Non-invasive Prenatal Testing Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Non-invasive Prenatal Testing Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Non-invasive Prenatal Testing Market Opportunities
3.4. Non-invasive Prenatal Testing Market Future Trends

4. Non-invasive Prenatal Testing Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Non-invasive Prenatal Testing Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Non-invasive Prenatal Testing Market Landscape

6.1. Non-invasive Prenatal Testing Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Non-invasive Prenatal Testing Market - By Test Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
- 7.1.2. Sequencing-based NIPT
- 7.1.3. Microarray-based NIPT
- 7.1.4. PCR-based NIPT

8. Non-invasive Prenatal Testing Market - By Technology

8.1. Overview
- 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
- 8.1.2. Next-Generation Sequencing (NGS)
- 8.1.3. Polymerase Chain Reaction (PCR)
- 8.1.4. Microarray
- 8.1.5. Others

9. Non-invasive Prenatal Testing Market - By Application

9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 9.1.2. Down Syndrome Screening
- 9.1.3. Edwards Syndrome Screening
- 9.1.4. Patau Syndrome Screening
- 9.1.5. Sex Chromosome Aneuploidy Screening
- 9.1.6. Others

10. Non-invasive Prenatal Testing Market - By End-user

10.1. Overview
- 10.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
- 10.1.2. Hospitals & Clinics
- 10.1.3. Diagnostic Laboratories
- 10.1.4. Research Institutes

11. Non-invasive Prenatal Testing Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Non-invasive Prenatal Testing Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Non-invasive Prenatal Testing Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.9. UK
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.3.9.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.9.6. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.10. France
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.10.6. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.11. Italy
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.11.6. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.12. Spain
  - 11.3.12.1. Overview
  - 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.3. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.12.6. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.13. The Netherlands
  - 11.3.13.1. Overview
  - 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.3. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.13.6. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Overview
  - 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.14.6. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.15. Russia
  - 11.3.15.1. Overview
  - 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.3. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.15.6. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.16. Poland
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.17. Rest of Europe
  - 11.3.17.1. Overview
  - 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.17.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Non-invasive Prenatal Testing Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.8. China
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.8.6. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.9. India
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.4.9.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.9.6. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.13. Indonesia
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.14. Thailand
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Non-invasive Prenatal Testing Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Non-invasive Prenatal Testing Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Non-invasive Prenatal Testing Industry

12.1. Competitive Dashboard
- 12.1.1. Competitive Benchmarking
- 12.1.2. Competitive Positioning
12.2. Company Profiles
- 12.2.1. Illumina, Inc.
- 12.2.2. Roche Diagnostics
- 12.2.3. BGI Genomics
- 12.2.4. Myriad Genetics, Inc.
- 12.2.5. Natera, Inc.
- 12.2.6. PerkinElmer, Inc.
- 12.2.7. Invitae Corporation
- 12.2.8. Thermo Fisher Scientific, Inc.
- 12.2.9. Laboratory Corporation of America Holdings (LabCorp)
- 12.2.10. QIAGEN N.V.
- 12.2.11. Berry Genomics Co., Ltd.
- 12.2.12. Agilent Technologies, Inc.
- 12.2.13. Eurofins Scientific
- 12.2.14. Fulgent Genetics
- 12.2.15. Genesis Genomics
- 12.2.16. GeneDx, Inc.
- 12.2.17. CooperGenomics
- 12.2.18. Congenica
- 12.2.19. GenePlanet
- 12.2.20. Integrated Genetics

13. 360 Degree AnalystView

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us